Expression of human somatostatin receptor subtype 3 in pancreatic cancer in vitro and in vivo

Journal of the National Cancer Institute

Volumn 90, Issue 21, 1998, Pages 1666-1668

  Raderer, Markus ^a,c   Pangerl, Thomas ^a   Leimer, Maria ^a   Valencak, Julia ^a   Kurtaran, Amir ^a   Hamilton, Gerhard ^b   Scheithauer, Werner ^a   Virgolini, Irene ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

RECEPTOR SUBTYPE; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER PATIENT; DRUG RECEPTOR BINDING; HUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032483743     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/90.21.1666     Document Type: Article

References (10)

1. Cascinu S, Del Ferro E, Catalano G. A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy. Br J Cancer 1995;71:97-101.
2. Buscail L, Saint-Laurent N, Chastre E, Vaillant JC, Gespach C, Capella G, et al. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. Cancer Res 1996;56:1823-7.
3. Fisher WE, Doran TA, Muscarella P 2nd, Boros LG, Ellison EC, Schirmer WJ. Expression of somatostatin receptor subtype 1-5 genes in human pancreatic cancer. J Natl Cancer Inst 1998;90:322-4.
4. Smith-Jones P, Bischof C, Leimer M, et al. DOTA-lanreotide: a novel tumor diagnostic and therapeutic somatostatin analog [abstract]. J Nucl Med 1998;38:223.
5. Scatchard G. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 1949;51:660-72.
6. Virgolini I, Yang Q, Li S, Angelberger P, Neuhold N, Niederle B, et al. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors. Cancer Res 1994;54:690-700.
7. Reubi JC, Horisberger U, Essed JE, Jeekel J, Klijn JG, Lamberts SW. Absence of somatostatin receptors in human exocrine pancreatic adenocarcinomas. Gastroenterology 1988; 95:760-3.
8. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, et al. Somatostatin receptor scintigraphy with [111 In-DTPA-D-Phel]- and [1231-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20: 716-31.
9. Sharma K, Srikant CB. G protein coupled receptor signaled apoptosis is associated with activation of a cation insensitive acidic endonuclease and intracellular acidification. Biochem Biophys Res Commun 1998;242: 134-40.
10. Raderer M, Kurtaran A, Yang Q, Meghdadi S, Vorbeck F, Hejna U, et al. 123I-vasoactive intestinal peptide (VIP)-receptor scanning in patients with pancreatic cancer: a novel tool in the diagnostic armamentarium. J Nucl Med 1998. In press.